Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tinwell

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Mutagenesis|July 1, 1993
Clastogenicity of chlorambucil to the mouse bone marrow: consideration in relation to its genetic specificity of action in some assaysJ Ashby, H Tinwell
BMJ (Clinical Research Ed.)|November 26, 2002
Thalidomide is not a human mutagenJ Ashby, H Tinwell
Mutation Research|May 1, 1995
Current issues in mutagenesis and carcinogenesis, No. 55. Activity of etoposide in the mouse bone marrow micronucleus test: independence of route of exposureJ Ashby, H Tinwell
Mutagenesis|May 1, 1994
Use of transgenic mouse lacI/Z mutation assays in genetic toxicologyJ Ashby, H Tinwell
Mutation Research|June 19, 2001
Continuing ability of the rodent bone marrow micronucleus assay to act as a predictor of the possible germ cell mutagenicity of chemicalsJ Ashby, H Tinwell
Mutation Research|August 1, 1994
Activity of 1,4-dioxane in mouse bone marrow micronucleus assaysH Tinwell, J Ashby
Nature|June 8, 1995
Is thalidomide mutagenic?J Ashby, H Tinwell
Mutation Research|March 1, 1995
A sequential approach to testing with the rodent bone marrow micronucleus assay--obviation of the need for statistical analyses of dataJ Ashby, H Tinwell
Carcinogenesis|August 1, 1994
Genetic toxicity and potential carcinogenicity of taxolH Tinwell, J Ashby
Environmental and Molecular Mutagenesis|January 1, 1991
Activity of the human carcinogen MeCCNU in the mouse bone marrow micronucleus assayH Tinwell, J Ashby
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Mutagenesis|July 1, 1993
Clastogenicity of chlorambucil to the mouse bone marrow: consideration in relation to its genetic specificity of action in some assaysJ Ashby, H Tinwell
BMJ (Clinical Research Ed.)|November 26, 2002
Thalidomide is not a human mutagenJ Ashby, H Tinwell
Mutation Research|May 1, 1995
Current issues in mutagenesis and carcinogenesis, No. 55. Activity of etoposide in the mouse bone marrow micronucleus test: independence of route of exposureJ Ashby, H Tinwell
Mutagenesis|May 1, 1994
Use of transgenic mouse lacI/Z mutation assays in genetic toxicologyJ Ashby, H Tinwell
Mutation Research|June 19, 2001
Continuing ability of the rodent bone marrow micronucleus assay to act as a predictor of the possible germ cell mutagenicity of chemicalsJ Ashby, H Tinwell
Mutation Research|August 1, 1994
Activity of 1,4-dioxane in mouse bone marrow micronucleus assaysH Tinwell, J Ashby
Nature|June 8, 1995
Is thalidomide mutagenic?J Ashby, H Tinwell
Mutation Research|March 1, 1995
A sequential approach to testing with the rodent bone marrow micronucleus assay--obviation of the need for statistical analyses of dataJ Ashby, H Tinwell
Carcinogenesis|August 1, 1994
Genetic toxicity and potential carcinogenicity of taxolH Tinwell, J Ashby
Environmental and Molecular Mutagenesis|January 1, 1991
Activity of the human carcinogen MeCCNU in the mouse bone marrow micronucleus assayH Tinwell, J Ashby
Pageof 10